Intercure Ltd.
corporate_fare Company Profile
Intercure Ltd. (NASDAQ:INCR) is a publicly traded company in the Life Sciences sector. Wiseek monitors INCR SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- InterCure Proposes 5-to-1 Reverse Split to Avert Nasdaq Delisting
- InterCure Secures $7M Private Placement, CEO Participates, to Fund Growth
- InterCure Secures $7.4M Private Placement, Potentially $18.6M, with CEO & Hedge Fund Investment
- InterCure Completes Initial Botanico Acquisition, Initiates Strategic Review of U.S. Medical Cannabis Market
- InterCure Completes Botanico Acquisition, Initiates Strategic Review for U.S. Medical Cannabis Market Entry
Financial Snapshot
Insider Transactions
INCR files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.